OpenEvidence

OpenEvidence Information overload is a common problem in many high-value domains. It's a huge challenge in medicine. With such a rate of change, it is practically impossible for the world's physicians, medical scientists, and healthcare professionals to keep up with and comprehend all of the most recent research literature and clinical evidence pertinent to their work. Our contribution to the global effort to tame the medical information firehose is OpenEvidence: Artificial intelligence is applied in our strategy to aggregate, synthesize, and visualize clinical evidence in intelligible, clinically valuable formats that can be exploited.

OpenEvidence headquartered in United States, North America, operates in the Medical, Clinical Trials sector. The company focuses on Medical and has secured $512.0M in funding across 16 round(s). With a team of 11-50 employees, OpenEvidence is actively contributing to advancements in Medical. Their latest funding round, Series B - OpenEvidence, raised $27.0M. Discover more about their projects, partnerships, and impact on our platform.